<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Endothelin-1 (ET-1) has been implicated in many <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological diseases</z:e>, including <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> (SAH) and <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>ET-1 is also proved to deteriorate the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion injury in many organs </plain></SENT>
<SENT sid="2" pm="."><plain>Our previous studies demonstrated that the endothelin-converting enzyme (ECE) inhibitor, CGS 26303, possessed beneficial effects for the treatment of SAH and transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we investigated the neuroprotective effect of CGS 26303 on the locomotor function and <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of <z:chebi fb="4" ids="30413">heme</z:chebi>-oxygenase-1 (HO-1) in rats subjected to a 15-min <z:e sem="disease" ids="C0752130" disease_type="Disease or Syndrome" abbrv="">spinal cord ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The results showed that pretreatment with CGS 26303 significantly preserved the locomotor function and decreased the <z:hpo ids='HP_0010550'>paraplegia</z:hpo> rate at Days 1 and 3 as compared with a saline-treated group </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, rats pretreated with CGS 26303 had a significant increase in the levels of HO-1 mRNA expression at Day 3 when compared with animals pretreated with saline after <z:e sem="disease" ids="C0752130" disease_type="Disease or Syndrome" abbrv="">spinal cord ischemia</z:e> and the sham operation group </plain></SENT>
<SENT sid="6" pm="."><plain>These results suggest that CGS 26303 may have a promising neuroprotective effect in the spinal cord after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion injury, and beneficial result may be due to an adaptive mechanism involved by HO-1 overexpression </plain></SENT>
</text></document>